semaglutide fda news warns about safety of 'off-brand' versions of Ozempic, Wegovy FDA approves weight-loss drug Wegovy

Albiglutide and dulaglutide, the other long-acting GLP-1 receptor agonists, each have a half-life of 5 days (16,17)

Pharmaceutical companies increasingly apply AI to: predict protein structures (e.g

Importantly, initiation of GLP-1RA may decrease levothyroxine dose requirements in patients with hypothyroidism through weight loss, enhance levothyroxine absorption due to delayed gastrointestinal (GI) transit, and have direct effects on the hypothalamic-pituitary-thyroid axis [23,24,25,26,27,28,29], potentially increasing the risk of thyroid hormone over-replacement (i.e., iatrogenic hyperthyroidism)

Caruso, I., Di Gioia, L., Di Molfetta, S